Heron Therapeutics reported 0 in Dividend Yield for its fiscal quarter ending in March of 2025.





Dy Change Date
Anika Therapeutics 0 0 Mar/2025
Eisai 3.88 0.6 Jun/2026
Emergent BioSolutions 0 0 Mar/2025
GlaxoSmithKline 0.86 0.03 Jun/2026
Heron Therapeutics 0 0 Mar/2025
Merck 2.62 0.14 Jun/2026
Nektar Therapeutics 0 0 Mar/2025
Omeros 0 0 Mar/2025
Regeneron Pharmaceuticals 0.58 0.12 Jun/2026
Roche Holding 2.94 0.01 Jun/2026
Sangamo BioSciences 0 0 Mar/2025